Key facts
- This page summarizes Chandler Robinson's Form 4 filing for Monopar Therapeutics (MNPR).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 08 Dec 2025, 16:46.
Chandler Robinson - 02 Dec 2025 Form 4 Insider Report for Monopar Therapeutics (MNPR)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- MNPR
- Reported as of
- 02 Dec 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 08 Dec 2025, 16:46:34 UTC
- Prior SEC filing
- 02 Oct 2025
- Next SEC filing
- 05 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Quan Vu, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Chandler Robinson filed Form 4 for Monopar Therapeutics (MNPR) on 08 Dec 2025.
Change
- Previous filing in this sequence was filed on 02 Oct 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001727334
Primary reporting owner
Robinson Chandler
- Relationship
- Chief Executive Officer, Director
- Address
- 1000 SKOKIE BLVD SUITE 350, WILMETTE
- Signature
- /s/ Quan Vu, Attorney-in-fact
- Signature date
- 08 Dec 2025
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MNPR
transaction
Derivative
Stock Options
Award
- Transaction value
- $0
- Shares
- +16,753
- Change %
- Price
- $0.000000
- Shares after
- 16,753
- Date
- 02 Dec 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 16,753
- Exercise price
- $75.94
- Footnotes
- F1
MNPR
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +49,133
- Change %
- +68%
- Price
- $0.000000
- Shares after
- 121,732
- Date
- 02 Dec 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 49,133
- Exercise price
- $0.000000
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Options vest 6/48ths on June 30, 2026, and 1/48th per month thereafter.
Footnote F2
RSUs vest 6/48ths on June 30, 2026, and 3/48ths per quarter thereafter.